BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeng X, Yuan X, Cai Q, Tang C, Gao J. Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases. Cells 2021;10:1945. [PMID: 34440714 DOI: 10.3390/cells10081945] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu M, Cao S, Guo Z, Wu Z, Meng J, Wu Y, Shao Y, Li Y. Roles and mechanisms of CircRNAs in ovarian cancer. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1044897] [Reference Citation Analysis]
2 Li B, Zhou J, Luo Y, Tao K, Zhang L, Zhao Y, Lin Y, Zeng X, Yu H. Suppressing circ_0008494 inhibits HSCs activation by regulating the miR-185-3p/Col1a1 axis. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1050093] [Reference Citation Analysis]
3 Selvakumar SC, Auxzilia Preethi K, Veeraiyan DN, Sekar D. The role of microRNAs on the pathogenesis, diagnosis and management of portal hypertension in patients with chronic liver disease. Expert Review of Gastroenterology & Hepatology 2022. [DOI: 10.1080/17474124.2022.2142562] [Reference Citation Analysis]
4 Liu F, Li S. Non-coding RNAs in skin cancers:Biological roles and molecular mechanisms. Front Pharmacol 2022;13:934396. [DOI: 10.3389/fphar.2022.934396] [Reference Citation Analysis]
5 Rodríguez-fragoso L, Rodríguez-lópez A, Sánchez-quevedo J. Models of Hepatotoxicity for the Study of Chronic Liver Disease. Animal Models and Experimental Research in Medicine [Working Title] 2022. [DOI: 10.5772/intechopen.106219] [Reference Citation Analysis]
6 Ye Y, Wang H, Gao J, Kostallari E. Editorial: Chronic Liver Disease: New Targets and New Mechanisms. Front Mol Biosci 2022;9:963630. [DOI: 10.3389/fmolb.2022.963630] [Reference Citation Analysis]
7 Czaja AJ. Epigenetic Aspects and Prospects in Autoimmune Hepatitis. Front Immunol 2022;13:921765. [DOI: 10.3389/fimmu.2022.921765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Gan C, Cai Q, Tang C, Gao J. Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis. Front Immunol 2022;13:896473. [DOI: 10.3389/fimmu.2022.896473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lan T, Qian S, Tang C, Gao J. Role of Immune Cells in Biliary Repair. Front Immunol 2022;13:866040. [PMID: 35432349 DOI: 10.3389/fimmu.2022.866040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Zhang C, Liu N. Noncoding RNAs in the Glycolysis of Ovarian Cancer. Front Pharmacol 2022;13:855488. [PMID: 35431949 DOI: 10.3389/fphar.2022.855488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang M, Yu F, Zhang Y, Zhang L, Chang W, Wang K. The Emerging Roles of Circular RNAs in the Chemoresistance of Gastrointestinal Cancer. Front Cell Dev Biol 2022;10:821609. [DOI: 10.3389/fcell.2022.821609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Dorairaj V, Sulaiman SA, Abu N, Abdul Murad NA. Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis. Biomedicines 2021;10:15. [PMID: 35052690 DOI: 10.3390/biomedicines10010015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Cai Q, Gan C, Tang C, Wu H, Gao J. Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease. Front Pharmacol 2021;12:784591. [PMID: 34887768 DOI: 10.3389/fphar.2021.784591] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
14 Sulaiman SA, Dorairaj V, Abdul Ghafar KN, Abdul Murad NA. Noncoding RNAs Interactions in Hepatic Stellate Cells during Hepatic Fibrosis. Livers 2021;1:263-85. [DOI: 10.3390/livers1040021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]